ICD-10 Code R15.1: Fecal Smearing
ICD-10 code R15.1 specifically represents fecal smearing (also known as scatolia), which is the deliberate or involuntary spreading of feces on surfaces, objects, or oneself.
Clinical Context and Populations
Fecal smearing is a distinct behavioral manifestation that differs from fecal incontinence. While the provided guidelines 1 extensively discuss fecal incontinence (FI) and fecal seepage—which involve involuntary loss of stool control—fecal smearing represents a separate clinical entity that typically occurs in specific patient populations:
Primary Patient Groups:
- Developmentally disabled adults with profound mental retardation who may use fecal smearing as a form of nonverbal aggression or communication 2
- Patients with dementia, where scatolia is associated with severe cognitive dysfunction, negative affect, and insomnia 3
- Psychiatric patients, where it may represent psychotic behavior or protest behavior 4
Key Distinguishing Features
The critical distinction is intentionality and context: Fecal smearing involves the manipulation and spreading of stool, whereas fecal incontinence involves involuntary leakage. This is why R15.1 exists as a separate code from R15.0 (incomplete defecation) and R15.9 (fecal incontinence, unspecified).
Clinical Characteristics:
- Often occurs in patients with severe cognitive impairment (IQ <20-25) 2
- Associated with behavioral and psychiatric disorders rather than purely physiological dysfunction
- May represent a form of communication in nonverbal patients 2
- Linked to insomnia and negative affect in dementia patients 3
Management Considerations
Unlike fecal incontinence, which requires the stepwise conservative approach detailed in the guidelines 1 (dietary modification, fiber supplements, pelvic floor biofeedback, loperamide for diarrhea), fecal smearing requires behavioral and psychiatric interventions:
- Risperidone has demonstrated effectiveness, reducing episodes from 15.2 ± 3 per month to 6.0 ± 1.8 at 6 months in developmentally disabled adults 2
- Dosing typically starts at 0.5 mg twice daily, titrated up to 4 mg total daily dose as needed 2
- Behavioral management strategies tailored to the underlying psychiatric or developmental condition
- Environmental modifications to reduce triggers in dementia or psychiatric patients
Important Caveat:
Do not confuse fecal smearing with fecal seepage from overflow incontinence. The latter involves retained stool in the rectum with passive leakage and responds to pelvic floor biofeedback therapy and rectal cleansing 1. Fecal smearing is an active behavioral phenomenon requiring entirely different therapeutic approaches.